Products & Services

FabRx - Products & Service

Pharmaceutical 3D Printer
Pharmaceutical 3D printer

FabRx has developed the world’s first GMP 3D printer for the production of personalised medicines, the M3DIMAKER™.

Find Out More

Printlets™️
Printlets™️

Our proprietary PRINTLETS™️ technology platform is suitable for most oral dosage forms and is specifically designed for the production of personalised medicines.

Find Out More

Software
Software

-Software for 3D printing (design, printing process control, quality asssurance, ...).
-AI driven software for formulations development  (M3DISEEN). Machine learning algorithms to help researchers with new formulations.

Find Out More

The world’s first pharmaceutical 3D printer for personalised medicines.

Using our proprietary Printlets™ technology, we can create a range of personalised medicines, composed of specific dosages, API combinations, shapes, sizes and release profiles.

Pre-clinical Formulation
Development
Pre-clinical Formulation
Development
  • Rapid Dose Evaluation
  • In Vitro and in Vivo Testing

Find Out More

Early Phase Clinical
Trials
Early Phase Clinical
Trials
  • First-in-Human (FIH) Studies
  • Phase I / II Clinical Trials
  • Adaptive Clinical Trials
  • Patient Acceptability and Taste Evaluation

Find Out More

Patient-centric Design and
Production
Patient-centric Design and
Production
  • Personalised Dosage and Design
  • Patient-Friendly Formulations
  • Multi-Drug Combinations
  • On-Demand Medicine Production

Find Out More

Projects Stage Pipeline

FabRx is involved in a number of projects with research organisations, universities and pharmaceutical companies to develop novel dosage forms using 3D printing. Our world-class team are experts in the field of pharmaceutical formulation and use our industry-leading technology platforms to develop next-generation dosage forms. From chewable, flavoured formulations for paediatric patients to multi-drug polyprintlets, FabRx is able to produce novel dosage forms that traditional manufacturing cannot.

Below is a pipeline of our current projects in a variety of disease and therapeutics areas. Get in contact to discuss how your formulation or research plans can benefit from the versatility of 3D printing.

Drug development Program
Formulation
Pre-clinical
Clinical

Oncology

Rare diseases

Metabolic Disorders

Transplants

Nutraceuticals

Partner Programs

Undisclosed Partner A1

Undisclosed Partner A2

Undisclosed Partner B1

Undisclosed Partner B2

Services and Capabilities

Pre-clinical Formulation
Development
  • Rapid Dose Evaluation
  • In Vitro and in Vivo Testing
Early Phase Clinical
Trials
  • First-in-Human (FIH) Studies
  • Phase I / II Clinical Trials
  • Adaptive Clinical Trials
  • Patient Acceptability and Taste Evaluation
Patient-centric Design and
Production
  • Personalised Dosage and Design
  • Patient-Friendly Formulations
  • Multi-Drug Combinations
  • On-Demand Medicine Production

We are happy to be collaborating with…

Schedule Your Consultation Today

Copyright © 2021 FabRx Ltd